The Proposed BPC 157 Cytoprotective Principle as the Counteraction of the Occlusion/Occlusion-like Syndromes Recently, regarding the particular point of resolving the application in eye pharmacotherapy, the pleiotropic beneficial effect as a particular cytoprotective agents ability was combined with the cytoprotective ability of the pentadecapeptide BPC 157 to further maintain and upgrade endothelium integrity and functioning (for review see [1,2,3,4,5,6,7,8,9,10])
doi:10.1016/j.abd.2020.06.021 104 Percinel, I
Frequently Asked Questions Does Tylenol depletion of glutathione cause permanent damage
[9] Wilding JPH, et al
However, neurodegenerative disease mechanisms differ substantially between animal models and human diseases, and premature clinical use based solely on animal data could expose patients to unknown risks without established benefits